Merck Expands Biosafety Testing Laboratory in Singapore to Strengthen Services Across Asia Pacific
3 Articles
3 Articles
Merck expands Singapore biosafety testing laboratory to over 1,000 square metres
SINGAPORE – Media OutReach Newswire – 11 August 2026 – Merck, a leading science and technology company, is expanding its Singapore lab to further strengthen analytical and biosafety testing services for customers across the Asia Pacific region. Biosafety testing is a critical step in the drug development and manufacturing process, helping to ensure that biologics are safe, effective, and compliant with regulatory requirements. The expansion buil…
Merck expands Singapore lab for biopharma testing
Merck is expanding its Singapore laboratory to strengthen analytical and biosafety testing services for customers across the Asia Pacific region. Biosafety testing is a step in the drug development and manufacturing process, helping to ensure that biologics are safe, effective and compliant with regulatory requirements. The expansion builds on Merck’s global testing expertise of more than 75 years and marks a milestone in providing a local contr…
Merck Expands Biosafety Testing Laboratory in Singapore to Strengthen Services Across Asia Pacific
Expansion adds first BioReliance® Cell Line Characterization and GMP Next-GenerationSequencingin Asia Pacific Enhanced testing capabilities to deliver speed, sensitivity, and sustainability for biopharma customers in the region Supports industry shift to molecular methods and animal-free testing SINGAPORE – Media OutReach Newswire – 11 August 2026 – Merck, a leading science and technology company, is expanding
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
